The largest database of trusted experimental protocols

Elisa plate reader

Manufactured by Molecular Devices
Sourced in United States, China

The ELISA plate reader is a lab equipment designed to measure the absorbance of samples in a 96-well microplate format. It is used to quantify the presence and concentration of specific analytes, such as proteins, antibodies, or small molecules, in a sample. The core function of the ELISA plate reader is to detect and measure the optical density of the colored end-product of an ELISA (Enzyme-Linked Immunosorbent Assay) reaction, which is proportional to the amount of target analyte present in the sample.

Automatically generated - may contain errors

99 protocols using elisa plate reader

1

Measuring Serum Immunoglobulins in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Forty-eight hours after the last challenge, the serum was prepared from blood obtained via cardiac puncture of mice. Total and OVA-specific immunoglobulins (IgE, IgG1, and IgG2a) were evaluated by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (R&D Systems, Minneapolis, MN, USA). Absorbance at 450 nm was determined using an ELISA plate reader (Molecular Devices, Sunnyvale, CA, USA).
+ Open protocol
+ Expand
2

Cell Viability Assessment of iSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell Counting Kit-8 (CCK-8, UEL-C6005; UElandy, Suzhou, China) was used to assess the cell viability of iSCs. After 24 h of transfection, iSCs were seeded into a 96-well plate at a density of 104 cells per well. CCK-8 medium was added to each well and incubated for 4 h at 37 °C. Values were measured at 450 nm using an ELISA plate reader (Molecular Devices, San Jose, CA, USA).
+ Open protocol
+ Expand
3

Cytotoxicity Evaluation of Synthesized Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity of synthesized compounds was tested utilizing MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. The cells were briefly seeded in triplicates into a 96-wells tissue culture plate at a density of 104 cells per well and incubated for 24 h at 37 °C with 5% CO2. The wells were then treated with the compounds tested at concentrations ranging from 5 to 300 μM and incubated further at 37 °C for 24 h. After the incubation period, the compounds were aspirated, and the wells were washed with phosphate-buffered saline (PBS). Afterward, 300 μL of media and 25 μL of MTT solution (5 mg mL−1 in PBS) were added to each well, followed by 3 h of incubation. Later, MTT was removed, and the formed crystal formazan was dissolved in 100 μL dimethyl sulfoxide (DMSO). The MTT assay absorbance was measured at 570 nm on an ELISA plate reader (Molecular Devices, USA). The relationship between surviving cells and drug concentration was plotted to get each cell line's survival curve after treatment with the specified compound. The 50% inhibitory concentration (IC50), the concentration required to cause toxic effects in 50% of intact cells, was estimated using nonlinear regression analysis using Graph pad prism (version 7.0) software.
+ Open protocol
+ Expand
4

Cytotoxicity and Hyperthermia Effects of MNPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity of MNPs was assessed by MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay. Briefly, 104 HeLa/ MCF7 cells per well were seeded in triplicates in a 96-wells tissue culture plate and grown for 24 h followed by treatment with magnetic fluid diluted in EMEM in the concentration range varying from 0.75 to 0.03 mg/mL. Two sets of triplicates served as untreated controls.
After incubation the magnetic fluid was removed and the cells were washed thrice with phosphate buffered saline (PBS) to ensure complete removal of MNPs from the wells. Thereafter, 300 μl of media and 25 μl of MTT solution (5 mg/mL in PBS) was added to each well followed by 3 h of incubation. Subsequently, media containing MTT was removed and the formed crystal formazan were dissolved in 100 µl dimethyl sulfoxide. The MTT assay absorbance was measured at 570 nm on an ELISA plate reader (Molecular Devices, USA). After obtaining the IC50 value we utilized the same assay to report our preliminary results of 24 h hyperthermic effect on breast cancer cell line MCF7.
+ Open protocol
+ Expand
5

ELISA for Serum Antibody Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plates (96-well) were coated with 100 μl of stabilized pre-F (1 μg/ml) or post-F (1 μg/ml) diluted in 1× PBS (pH 7.4) and incubated overnight at 4°C. The plates were washed with wash buffer (0.2% Tween 20 in 1× PBS) and had 200 μl of 2% BSA (in 1×PBS) added per well as a blocking buffer. Plates were then incubated for 1 hour at RT. Three tubes containing 100 μl (1:10 dilution) of unadsorbed serum, serum adsorbed with pre-F, and serum adsorbed with post-F were added to pre-F– and post-F–coated wells. The plates were incubated for 1 hour at RT, washed, and coated with 100 μl of goat anti-human IgG (1:5000, Santa Cruz Biotechnology). After 1 hour of incubation, the plates were washed, and 100 μl of Super AquaBlue substrate (eBioscience Inc.) was added to each well. An ELISA plate reader (Molecular Devices LLC) was used to read signals at 538-nm wavelength.
+ Open protocol
+ Expand
6

Cell Viability Assay Using MTS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 10,000 cells/well on 96-well plates in normal medium. The cells were treated either with siRNA for 48h in complete media. Cell viability was monitored using the CellTiter 96 Aqueous One Solution cell proliferation assay (Promega), on the basis of the cellular conversion of the colorimetric reagent MTS
tetrazolium salt] into soluble formazan by dehydrogenase enzymes found only in metabolically active cells. Following treatment cells were incubated with reagent solution and absorbance was recorded at 490 nm wavelength using an ELISA plate reader (Molecular Devices).
+ Open protocol
+ Expand
7

MTS-Based Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was measured based on cellular conversion of the colorimetric reagent 3,4-(5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) into soluble formazan by a dehydrogenase enzyme found in metabolically proliferating cells (CellTiter 96 Aqueous One Solution cell proliferation assay; Promega, Madison, WI). Following each treatment, 20 μL of dye solution was added into each well in a 96-well plate and incubated for 2 hours. Absorbance was recorded at a wavelength of 490 nm using an enzyme-linked immunosorbent assay (ELISA) plate reader (Molecular Devices, Sunnyvale, CA, USA).
+ Open protocol
+ Expand
8

Quantifying Cell Proliferation Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was examined using the cell counting kit-8 (CCK-8) (Multiscience, Hangzhou, China) and 5-ethynyl-2′-deoxyuridine (EdU) (RiboBio, Guangzhou, China) incorporation assays. Cells were seeded in a 96-well culture plate at a density of 1 × 104 cells/well in 100 μL culture medium. For the CCK-8 assay, 10 μL CCK-8 medium was added in each well at 0 h or 24 h after transfection. Then, cells were incubated for 4 h at 37 °C. The absorbance value of each well was detected using an ELISA plate reader (Molecular Devices, San Francisco, CA, USA) at 450 nm. For the EdU assay, 100 μL EdU medium (50 μmol) was added in each well 24 h after transfection, and cells were incubated for 2 h at 37 °C. Then, DNA staining solution and EdU staining solution were added in each well to mark living cells (blue) and the proliferating (red) cells according to the manufacturer’s protocols, respectively. We used a fluorescence microscope to observe the cells at 20× and the ImageJ software to determine cell numbers.
+ Open protocol
+ Expand
9

IgG Avidity ELISA for Antibody Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant Pfs25 or VAR2CSA (1 µg/ml in PBS) was coated on Nunc MaxiSorp plates overnight at 4 °C. Plates were incubated with blocking buffer (1 % BSA) for 1 h at room temperature (RT). Plates were washed three times in between different steps. Before adding the anti-sera for incubation with the capture antigen, IgG levels in individual serum samples were equalized by dilution. This was done based on pre-determined OD490 ELISA values. IgG-normalized serum samples were added (50 µl per well) to the ELISA plate in triplicates, and incubated for 1 h at RT. The ELISA wells were subsequently washed three times in PBS with 0.05 % TWEEN 20 and 50 µl of freshly made 8 M Urea was then added to the wells for 5 min (reference plates were incubated with PBS). ELISA plates were then washed three times with PBS (0.05 % TWEEN 20). HRP-conjugated polyclonal goat anti-mouse IgG (A16072, Life Technologies, Denmark) was diluted 1:3000 in blocking buffer and incubated for 1 h. Finally, color reactions were developed for 7 min by adding o-phenylenediamine substrate. The HRP enzymatic reaction was stopped by adding 2.5 M H2SO4 and the optical density was measured at 490 nm using an ELISA plate reader (VersaMax Molecular Devices). IgG avidity index values were calculated as the ratio of the mean OD value of urea-treated wells to PBS control wells multiplied by 100.
+ Open protocol
+ Expand
10

Quantifying Adoptive Transfer of IgM

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified FoB cells were isolated from C57BL/6-C20-CD45.1 mice congenic for Igha and adoptively transferred into B6 or Rag2–/– mice. Recipients were bled at days 0, 7, 14, 21, and 30 and serum was isolated by centrifugation. Nunc Maxisorb 96-well flat-bottom plates (Thermo Fisher Scientific) were coated with 10 μg/mL F(ab’)2 fragment goat anti-mouse IgM in sodium bicarbonate buffer and blocked with 2% BSA/PBS. Serum was serially diluted across the plate and incubated overnight at 4°C. For detection, biotin anti-mouse IgMa (Igh-6a, BD Pharmingen) and biotin anti-mouse IgMb (AF6-78, BioLegend) were diluted in blocking buffer and added at 1:3000 for 2 hours at room temperature followed by streptavidin-HRP (BD Pharmingen) at 1:10,000 for 1 hour at room temperature. Wells were developed with 3,3’,5,5’-Tetramethylbenzidine substrate solution and stopped with phosphoric acid. Plates were read on an ELISA plate reader (Molecular Devices). Concentrations were extrapolated from a standard curve generated based off the absorbance of normal mouse serum from a C57BL/6-C20-CD45.1 donor.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!